"Multiple myeloma; bortezomib; cardio-oncology; cardiotoxicity; carfilzomib; ixazomib; proteasome inhibitors"

Multiple myeloma is a malignant disease, caused by an uncontrolled clonal proliferation of a specific group of white blood cells, the plasma cells. Clinical manifestations include bone pain due to osteolysis, hypercalcemia, anemia, and renal …